Parallel Advisors, LLC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 32 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,015,966
-27.7%
1,693,5590.0%0.03%
-24.4%
Q2 2023$1,405,993
+135.4%
1,693,5590.0%0.04%
+125.0%
Q1 2023$597,318
-17.5%
1,693,5590.0%0.02%
-35.5%
Q4 2022$724,166
-25.3%
1,693,5590.0%0.03%
-31.1%
Q3 2022$969,000
-59.7%
1,693,5590.0%0.04%
-59.1%
Q2 2022$2,405,000
-12.4%
1,693,559
+150.0%
0.11%
+0.9%
Q1 2022$2,744,000677,4520.11%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$9,687,0004.74%
Abingworth LLP 4,822,114$6,462,0002.07%
OUP Management Co., LLC 1,025,697$1,456,0002.00%
Column Group LLC 4,309,329$6,119,0001.30%
Evolution Capital Management LLC 527,885$750,0001.12%
SECTORAL ASSET MANAGEMENT INC 2,382,644$3,383,0000.68%
Parallel Advisors, LLC 1,693,559$2,405,0000.11%
RESOLUTE FINANCIAL, LLC 30,000$43,0000.04%
Oasis Management Co Ltd. 100,000$142,0000.02%
Blackstone Inc. 1,308,587$1,858,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders